Cipladine Powder
₹50
₹90.03
₹50
₹90.03
Coupons & Offers
No Return or Exchange
Fast Delivery
Highlights
composition with strength
Povidone Iodine(0.05)
dosage form
Powder
description
Effective antiseptic powder for managing skin infections from minor cuts, wounds, scraps and burns, contains povidone-iodine that rapidly penetrates microorganisms to prevent infection spread
product type
Antiseptic Liquid
unit
10 g
packaging type
Bottle
how to use
For external use only. Follow your doctor's advice and check the label for directions before use
ideal for
Adults
pack of
1
weight
10 g
application area
Skin
item form
Powder
consume type
Topical
key features
Treats minor cuts and burns effectively, Prevents spread of skin infections, Promotes faster wound healing
Information
customer care details
In case of any issue, contact us E-mail address: support@zeptonow.com
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship. While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
Seller License No.
11521998000248
Manufacturer Name
Cipla Limited
Country of Origin
India
Shelf Life
36 months
Expires on or after
November 2025